Invention Grant
US06723718B2 Substituted &agr;, &bgr;-anellated butyrolactones 失效
取代的α,β-蒽醌丁内酯

Substituted &agr;, &bgr;-anellated butyrolactones
Abstract:
The present invention relates to novel substituted &agr;,&bgr;-fused butyrolactones, to processes for their preparation and to their use for the prevention and/or treatment of disorders caused by hyper- or hypofunction of the glutamatergic system, in particular of cerebral ischaemias, craniocerebral trauma, states of pain or CNS-mediated spasms.
Public/Granted literature
Information query
Patent Agency Ranking
0/0